Trial Details
RECRUITINGBasic Information
| Clinical ID | c173 |
|---|---|
| Identifier | NCT07035041 |
| Trial Title | A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | UC - Ulcerative Colitis|Moderately to Severely Active Ulcerative Colitis |
| Interventions | DRUG: D-2570|DRUG: Placebo |
Participant Information
| Sponsor | InventisBio Co., Ltd |
|---|---|
| City | Zhejiang |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-05-22 |
|---|---|
| Primary Completion Date | 2026-07-30 |
| Completion Date | 2026-12-31 |